Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

• Main Authors: Alexa B. Kimball (Author), Dimittri Delevry (Author), Min Yang (Author), Chien-Chia Chuang (Author), Zhixiao Wang (Author), Gaëlle Bégo- (Author), Bruno Martins (Author), Eric Wu (Author), Brad Shumel (Author), Jessie Wang (Author), Debra Sierka (Author), Jingdong Chao (Author), Bruce Strober (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Atopic dermatitis (AD) can require long-term therapy. Few real-world studies have evaluated long-term effectiveness from the patients' perspective. The aim of this study was to evaluate patient-reported outcomes (PROs) during long-term dupilumab treatment. Methods Adults w...